{"schema_version":"1","generated_at":"2026-11-12T22:36:27.295Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kenneth-hancock","json_url":"https://www.findmykol.com/kol/kenneth-hancock/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kenneth-hancock","name":"Kenneth Hancock","credential":"MD","specialty":"Gynecologic Oncology","specialty_raw":"Gynecologic Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Fort Worth","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1467495325","openalex":"A5112215326"},"summary":"Kenneth Hancock is an Oncology physician. OpenAlex indexes 8 publications with 627 citations (h-index 7).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":8,"cited_by_count":627,"h_index":7,"latest_activity_year":2023,"source":"works"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"Eisai Inc.","program_year":2023,"amount_usd":67.19,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1467495325"},{"payer":"Genmab U.S., Inc.","program_year":2023,"amount_usd":40.76,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1467495325"},{"payer":"GlaxoSmithKline, LLC.","program_year":2023,"amount_usd":32.45,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1467495325"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1467495325","source":"payments"},"prescribing":{"data_year":2023,"areas_total":6,"areas_shown":3,"areas":[{"area":"Sensory organs","share_pct":55.4,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"administered","share_pct":55.4,"drugs":[{"name":"Dexamethasone sodium phosphate","share_pct":100}],"max_beneficiaries":22}]},{"area":"Metabolism & gastrointestinal","share_pct":31.2,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"administered","share_pct":31.2,"drugs":[{"name":"Granisetron hydrochloride","share_pct":100}],"max_beneficiaries":12}]},{"area":"Cancer & immunology","share_pct":5.3,"classes_total":1,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":5.3,"drugs":[{"name":"Letrozole","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":8,"shown":5,"withheld":3,"matched_by":"OpenAlex author record","recent":[{"title":"Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer","year":2016,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2016.09.018","status":"verified"},{"title":"A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer","year":2010,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2010.05.033","status":"verified"},{"title":"Phase II Evaluation of Nanoparticle Albumin–Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer","year":2009,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2008.18.9548","status":"verified"},{"title":"Results of an Open-Label Study to Evaluate the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Carboplatin-Containing Chemotherapy in Patients with Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Carcinoma (Stage I-IV) or Papillary Serous Cancer of the Uterus","year":2008,"journal":"Clinical Ovarian Cancer","source_url":"https://doi.org/10.3816/coc.2008.n.006","status":"verified"},{"title":"Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer","year":2002,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1006/gyno.2001.6581","status":"verified"}],"source":"works"},"contact":{"address_1":"500 S HENDERSON ST STE 200","city":"Fort Worth","state":"TX","zip":"761042154","phone":"174-131-5008","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1467495325","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"publications":3}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-12-09","provider_certified":"2021-12-09","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}